All Stories

  1. Structure of the full‐length insecticidal protein Cry1Ac reveals intriguing details of toxin packaging into in vivo formed crystals
  2. Small-molecule phosphodiesterase probes: discovery of potent and selective CNS-penetrable quinazoline inhibitors of PDE1
  3. The Enzymology of alanine aminotransferase (AlaAT) isoforms from Hordeum vulgare and other organisms, and the HvAlaAT crystal structure
  4. Role of Unusual P Loop Ejection and Autophosphorylation in HipA-Mediated Persistence and Multidrug Tolerance
  5. Discovery of Brain-Penetrant, Irreversible Kynurenine Aminotransferase II Inhibitors for Schizophrenia
  6. New kinase regulation mechanism found in HipBA: a bacterial persistence switch
  7. Crystal structure of the Yersinia pestis GTPase activator YopE
  8. Structural evidence for substrate-induced synergism and half-sites reactivity in biotin carboxylase
  9. Corrigendum to “Design and synthesis of potent, non-peptidic inhibitors of HPTPβ” [Bioorg. Med. Chem. Lett. 16 (2006) 4252–4256]
  10. Farnesyl pyrophosphate synthase enantiospecificity with a chiral risedronate analog, [6,7-dihydro-5H-cyclopenta[c]pyridin-7-yl(hydroxy)methylene]bis(phosphonic acid) (NE-10501): Synthetic, structural, and modeling studies
  11. Rational protein engineering in action: The first crystal structure of a phenylalanine tRNA synthetase from Staphylococcus haemolyticus
  12. The interaction of sidechain nitrogen with active site threonine is not essential for inhibition of farnesyl pyrophosphate synthase by nitrogen containing bisphosphonates
  13. Structural biology approaches to antibacterial drug discovery
  14. The development of 2-benzimidazole substituted pyrimidine based inhibitors of lymphocyte specific kinase (Lck)
  15. Engineering the catalytic domain of human protein tyrosine phosphatase β for structure-based drug discovery
  16. Serendipitous discovery of novel bacterial methionine aminopeptidase inhibitors
  17. Design and synthesis of substituted pyridine derivatives as HIF-1α prolyl hydroxylase inhibitors
  18. Design and synthesis of a series of novel pyrazolopyridines as HIF 1-α prolyl hydroxylase inhibitors
  19. Structure-based design, synthesis, and SAR evaluation of a new series of 8-hydroxyquinolines as HIF-1α prolyl hydroxylase inhibitors
  20. A novel series of imidazo[1,2-a]pyridine derivatives as HIF-1α prolyl hydroxylase inhibitors
  21. Design and synthesis of novel N-sulfonyl-2-indole carboxamides as potent PPAR-γ binding agents with potential application to the treatment of osteoporosis
  22. Structural basis for the fast maturation of Arthropoda green fluorescent protein
  23. MALDI-TOF MS as a label-free approach to rapid inhibitor screening
  24. 1,2,3,4-Tetrahydroisoquinolinyl sulfamic acids as phosphatase PTP1B inhibitors
  25. The Structure of Yersinia pestis V-Antigen, an Essential Virulence Factor and Mediator of Immunity against Plague
  26. Similar modes of polypeptide recognition by export chaperones in flagellar biosynthesis and type III secretion
  27. Mechanism of insulin sensitization by BMOV (bis maltolato oxo vanadium); unliganded vanadium (VO4) as the active component
  28. Differential effects of short affinity tags on the crystallization ofPyrococcus furiosusmaltodextrin-binding protein
  29. Three-dimensional structure of the type III secretion chaperone SycE fromYersinia pestis
  30. Unusual molecular architecture of the Yersinia pestis cytotoxin YopM: a leucine-rich repeat protein with the shortest repeating unit 1 1Edited by R. Huber
  31. Structure of the N-terminal domain ofYersinia pestisYopH at 2.0 Å resolution
  32. Structures of furanosides: geometrical analysis of low-temperature X-ray and neutron crystal structures of five crystalline methyl pentofuranosides
  33. Structural basis for oligosaccharide recognition by Pyrococcus furiosus maltodextrin-binding protein
  34. Overproduction, purification, crystallization and preliminary X-ray diffraction analysis of YopM, an essential virulence factor extruded by the plague bacteriumYersinia pestis
  35. Structures of Furanosides:  A Study of the Conformational Space of Methyl α- d -Lyxofuranoside by Density Functional Methods
  36. Anti-Human Immunodeficiency Virus Activity of Novel Aminoglycoside-Arginine Conjugates at Early Stages of Infection
  37. Aminoglycoside−Arginine Conjugates That Bind TAR RNA:  Synthesis, Characterization, and Antiviral Activity †
  38. Arginine-aminoglycoside conjugates that bind to HIV transactivation responsive element RNA in vitro
  39. Structures of Furanosides:  Density Functional Calculations and High-Resolution X-ray and Neutron Diffraction Crystal Structures